To better fight lung cancer, TUNC –Chapel Hill and Vanderbilt University researchers have been working on an extremely bendy but sturdy robot capable of traversing lung tissue to deal with very small, hidden tumors.
Read More
Biofidelity, a medtech company with a lab in Morrisville, is launching new technology with the goal of helping lung cancer patients access targeted treatments. Read more about their new tech—and their plans to grow in RTP.
Read More
Labcorp (NYSE: LH)’s new test expands the firm’s testing solutions for new precision medicines used to treat patients with lung cancer.
Read More
EQRx, based in Cambridge, Mass., will gain exclusive rights to G1’s lerociclib in the United States, Europe, Japan and all other global markets, excluding the Asia-Pacific region (except Japan).
Read More
UNC Chapel Hill professor Ron Alterovitz and his group are developing a new medical robot that can enable “earlier, less invasive, and more accurate” diagnosis of lung cancer.
Read More
